Skyhawk Therapeutics

Skyhawk Therapeutics

featured image of Ipsen's $18bn Pipeline Expansion Targets Movement Disorders
Companies

Ipsen’s $18bn Pipeline Expansion Targets Movement Disorders

BIOT

🔬 Ipsen SA and Skyhawk Therapeutics Inc join forces in a groundbreaking $1.8bn deal to treat rare neurological disorders. 💪🧠

Bioprocessupdates

©2023 - 2025 BioprocessUpdates

PRIVACY POLICY terms of service contact